Anzeige
Mehr »
Sonntag, 26.10.2025 - Börsentäglich über 12.000 News
Das nächste Lila Sciences? Telescope Innovations ist das 30-Millionen-Dollar-Tor zu KI-gesteuerter Chemie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J5EY | ISIN: US66737P6007 | Ticker-Symbol: NBYB
Stuttgart
24.10.25 | 18:47
0,208 Euro
-8,77 % -0,020
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
NORTHWEST BIOTHERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
NORTHWEST BIOTHERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur NORTHWEST BIOTHERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrNorthwest Biotherapeutics, Inc.: Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed283BETHESDA, Md., Oct. 24, 2025 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune...
► Artikel lesen
FrNORTHWEST BIOTHERAPEUTICS INC - 8-K, Current Report2
14.10.Northwest Biotherapeutics legt Rechtsstreit bei und storniert 17 % der Optionszuteilungen von 20207
14.10.NORTHWEST BIOTHERAPEUTICS INC - 8-K, Current Report4
27.08.Northwest Biotherapeutics, Inc.: Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.499BETHESDA, Md., Aug. 27, 2025 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies...
► Artikel lesen
18.08.Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman492BETHESDA, Md., Aug. 18, 2025 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for...
► Artikel lesen
NORTHWEST BIOTHERAPEUTICS Aktie jetzt für 0€ handeln
14.08.NORTHWEST BIOTHERAPEUTICS INC - 10-Q, Quarterly Report3
11.06.Northwest Biotherapeutics, Inc.: Northwest Biotherapeutics Announces Upcoming Presentation On Next Generation Dendritic Cells for Enhanced Anti-Tumor Treatments450BETHESDA, Md., June 11, 2025 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for...
► Artikel lesen
15.05.NORTHWEST BIOTHERAPEUTICS INC - 10-Q, Quarterly Report7
26.12.24Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing700BETHESDA, Md., Dec. 26, 2024 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for...
► Artikel lesen
10 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1